Metraipolis › archive › dc_0438bb03a228

Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome — Europe PMC PMID:41419472

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41419472
DOI
10.1038/s41467-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-07T12:52:25.281Z
SHA-256 of the archived text
a62250f5f408b3778736d449d0dbbe4dc1325f3852c3f4fba09712587ec76841
Stable URL of this page
https://metraipolis.com/documento/dc_0438bb03a228

How to cite

Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome — Europe PMC PMID:41419472 — Europe PMC (en), https://europepmc.org/article/MED/41419472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0438bb03a228 (Metraipolis archive dc_0438bb03a228, sha256 a62250f5f408b3778736d449d0dbbe4dc1325f3852c3f4fba09712587ec76841)
BibTeX
@misc{dc0438bb03a228,
  title = {Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome — Europe PMC PMID:41419472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41419472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0438bb03a228; sha256 a62250f5f408b3778736d449d0dbbe4dc1325f3852c3f4fba09712587ec76841},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41419472. Agents can read the archived copy with the MCP tool read_document.